AI-driven nerve stimulation shows significant improvement in essential tremor symptoms, offering a noninvasive treatment ...

The expanded FDA clearance makes NeurAxis’ IB-Stim the first FDA approval for a treatment that specifically addresses ...

CARMEL, Ind., Oct. 22, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children ...

TENS-electrical-therapy_G_505722027 Transcutaneous electrical nerve stimulation may be ineffective in treating, relieving lower back pain when compared with other nerve stimulation therapies.

Transcutaneous Electrical Nerve Stimulation (TENS) is a widely investigated non‐invasive modality for alleviating both acute and chronic pain. By delivering controlled electrical impulses via surface ...

Four weeks of active transcutaneous electrical nerve stimulation, or TENS, can significantly improve pain triggered by movement and other clinical outcomes among women with fibromyalgia, according to ...

A Transcutaneous Electrical Nerve Stimulation (TENS) device is, put bluntly, a machine for giving electric shocks. The author was prescribed such a device on loan by his orthopaedic specialist. A ...

CMS announced that it will no longer cover most uses of transcutaneous electrical nerve stimulation for chronic low back pain. In a memo released Friday and effectively immediately, CMS officials ...

CARMEL, Ind., Oct. 22, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing ...